Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Unaudited financial results for the quarter ended June 30, 2026.
Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.
Filed with BSE · · 1 page · English
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Story so far
- Board Meeting Intimation for Audited Standalone Financial Results Of The Company For The Quarter And Year Ended March 31, 2026.
- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025.
- Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter Ended September 30, 2025.
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 29 2026
- Announcement under Regulation 30 (LODR)-Allotment
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 14 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jun 27 2026
Later from Venmax Drugs & Pharmaceuticals
- Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026.
- Unaudited Financial Results For The Quarter Ended June 30, 2026.
- Statement Of Deviation & Variation
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 07 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals